Prescription Patterns, Initiation, and 5-Year Adherence to Adjuvant Hormonal Therapy Among Commercially Insured Patients With Breast Cancer

Tamoxifen and aromatase inhibitors (AIs) are used as adjuvant hormonal therapy (AHT) for early-stage hormone receptor–positive (HR+) breast cancer. Treatment for 5 years reduces cancer mortality by 30%. Despite this benefit, adherence to AHT has been suboptimal. Here, we evaluated AHT initiation and...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:JCO Oncol Pract
Main Authors: Zhao, Hui, Lei, Xiudong, Niu, Jiangong, Zhang, Ning, Duan, Zhigang, Chavez-MacGregor, Mariana, Giordano, Sharon H.
Formato: Artigo
Idioma:Inglês
Publicado em: Wolters Kluwer Health 2021
Assuntos:
ORIGINAL CONTRIBUTIONS
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8257979/
https://ncbi.nlm.nih.gov/pubmed/33596096
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/OP.20.00248
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados